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ABSTRACT: A novel membrane contactor method was used to produce size-controlled 
poly(ethylene glycol)-b-polycaprolactone (PEG-PCL) copolymer micelles composed of 
diblock copolymers with different average molecular weights, Mn (9200 or 10400 Da) and 
hydrophilic fractions, f (0.67 or 0.59). By injecting 570 l m-2 h-1 of the organic phase (a 1 mg 
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ml-1 solution of PEG-PCL in tetrahydrofuran) through a microengineered nickel membrane 
with a hexagonal pore array and 200 µm pore spacing into deionized water agitated at 700 
rpm, the micelle size linearly increased from 92 nm for a 5-µm pore size to 165 nm for a 40-
µm pore size. The micelle size was finely tuned by the agitation rate, transmembrane flux and 
aqueous to organic phase ratio. An encapsulation efficiency of 89 % and a drug loading of 
∼75 % (w/w) were achieved when a hydrophobic drug (vitamin E) was entrapped within the 
micelles, as determined by ultracentrifugation method. The drug-loaded micelles had a mean 
size of 146 ± 7 nm, a polydispersity index of 0.09 ± 0.01, and a zeta potential of -19.5 ± 0.2 
mV. When drug-loaded micelles where stored for 50 h, a pH sensitive drug release was 
achieved and a maximum amount of vitamin E (23 %) was released at the pH of 1.9. When a 
pH-sensitive hydrazone bond was incorporated between PEG and PCL blocks, no significant 
change in micelle size was observed at the same micellization conditions.  
KEYWORDS: Polymeric micelles; pH-sensitivity; Membrane contactor; Stirred cell; Vitamin 
E encapsulation; Hydrazone bond. 
 
INTRODUCTION 
In recent years, there has been growing interest in drug delivery using nano-carriers such as 
liposomes, core-shell nanocapsules, solid lipid nanoparticles, and micelles. Polymeric 
micelles are self-assembled aggregates of amphiphilic polymers consisting of a hydrophobic 
inner core and hydrophilic outer shell.1 The core can be used to solubilize drugs with poor 
water solubility, while the hydrophilic shell can prolong circulation time in blood by 
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inhibiting opsonins from adsorption on the micelle surface. Long circulation time in vivo is 
ensured by the micelle size of less than 200 nm.2 Particles with such a small size remain 
undetected by reticuloendothelial systems (RES),3 which can be exploited to achieve 
prolonged therapeutic action.4  
Micelles can be modified by incorporation of various functional groups and bonds to achieve 
targeted or triggered release. Of the many stimuli that can be exploited, changes in pH are 
particularly interesting because significant pH gradients can be found physiologically, for 
instance between normal tissues and some pathological sites, between the extracellular 
environment and some cellular compartments, and along the gastrointestinal tract. Some 
pathological states are associated with pH profiles different from that of normal tissues. 
Examples include ischemia, infection, inflammation and tumor acquisition, which are often 
associated with acidosis.5 Compared to normal blood pH of 7.4, extracellular pH values in 
cancerous tissues can be as low as 5.7 due to rapid expansion of tumor cells, leading to 
production of lactic acid and hydrolysis of ATP in an energy-deficient manner.6 To achieve 
pH sensitivity, the hydrophobic block of the copolymer can be modified to introduce acid-
liable bonds which degrade at mildly acidic pH, causing the micelle to collapse, thus 
releasing the encapsulated drug. The examples of pH sensitive groups are acetal bonds7-8 and 
poly(ortho ester) side chains9 that allow chemical conjugation of drugs to the side chain.  
There is a plethora of methods available for the preparation of polymeric micelles. If a 
copolymer is soluble in water, micellization is usually performed by direct dissolution in 
water or film casting. If a copolymer is insoluble in water, the most common methods are 
dialysis, oil-in-water (O/W) emulsion and co-solvent evaporation or displacement. The direct 
dissolution consists of dissolving polymer and drug in water. The method is not widely 
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applicable, since both blocks of the copolymer and the drug should be readily soluble in 
water. The method has been applied successfully for the encapsulation of hydrophobic drugs, 
but produced micelles are large and polydisperse.10 In film casting, polymer and drug are 
dissolved in a volatile organic solvent, which after evaporation leaves a thin drug-
impregnated film. Micelles are formed upon addition of warm water and stirring. The method 
is often used when other methods give poor drug loading efficiencies, as is the case with 
paclitaxel.11 Micelles produced by film casting typically have large sizes and bimodal size 
distributions.12 In order to avoid detection by the RES and premature elimination, the micelle 
solution must be filtered, which results in drug losses and poor yields. In the dialysis method, 
drug and polymer are dissolved in a water-miscible organic solvent followed by dialysis to 
replace the organic solvent with water. The technique generally yields large micelles with low 
drug contents13 and lacks reproducibility.14 These problems can be partially addressed by 
adding water to the polymer/drug solution prior to the dialysis, which kinetically freezes the 
micelles.15 Dialysis often requires days to complete and is difficult to scale up. In the O/W 
emulsion technique, polymer and drug are dissolved in a water-immiscible organic solvent 
and this mixture is then emulsified followed by evaporation of the organic solvent. The co-
solvent evaporation method is similar, except that the organic solvent is miscible with 
water.16 This method is often more suitable than the emulsion method, since it leads to the 
formation of smaller micelles with higher drug loading17 and ICH (International Conference 
on Harmonization) class 2 solvents, such as chloroform and dichloromethane, can be 
avoided.18 Therefore, most of the established techniques for micelle formation are not suitable 
for scaling-up from laboratory level to industrial production and suffer from low 
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reproducibility and poor control over the micelle size.19 Thus, there is a strong need for 
improvements in micelle preparation techniques.  
The main objective of this work was to develop and investigate a novel membrane dispersion 
method for micelle preparation, suitable for large scale production. Membranes are 
increasingly used for fabrication of emulsions and particles20 including nanoparticles such as 
solid lipid nanoparticles,21 liposomes,22 and nanoemulsions.23 However, to the best of our 
knowledge, fabrication of micelles by dispersion through a microporous membrane has never 
been reported. 
 
EXPERIMENTAL SECTION 
Reagents. Poly(ethylene glycol) methyl ether (Mn ~5000 Da) (PEG), ε-caprolactone 
monomer 99% (ε-CL), tin(II) 2-ethylhexanoate 95%, Sn(Oct)2, and sodium silicotungstate 
were supplied by Sigma-Aldrich. Toluene, extra dry grade, was purchased from Acros 
Organics. PEG was dried by azeotropic distillation with toluene prior to the polymerization 
reaction. ε-CL was dried prior use by distillation under reduced pressure onto 3A molecular 
sieves. O-[2-(6-Oxocaproylamino)ethyl]-O′-methylpolyethylene glycol (Mn = 5000 g/mol), 
PEG-CHO, and  2-hydroxyethylhydrazine 98%, 2-HEH, were purchased from Sigma-Aldrich 
Co Ltd, Gillingham, Dorset, UK. Tetrahydrofuran (THF) and acetone of analytical grade 
were purchased from Fischer Scientific and used without further purification. Ultra-pure 
water was obtained from a Millipore Synergy® system (Ultrapure Water System, Millipore). 
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Equipment. The micelles suspension was prepared using a stirred cell with a flat disc 
membrane fitted under the paddle blade stirrer, as shown in Figure 1 (a).  
 
 
 
 
Figure 1. (a) Schematic illustration of the stirred cell with simple paddle stirrer above a flat 
disc membrane (b = 12 mm, D = 32 mm, Dm = 33 mm, and T = 40 mm). (b) Schematic 
diagram of the experimental set-up. 
Both stirred cell and membranes were supplied by Micropore Technologies Ltd. (Hatton, 
Derbyshire, UK). The agitator was driven by a 24 V DC motor (INSTEK model PR 3060) 
and the paddle rotation speed was controlled by the applied voltage. The membranes used 
(a) 
(b) 
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were nickel membranes with regular hexagonal pore array containing uniform cylindrical 
pores with a diameter of 5, 10, 20 or 40 µm, arranged at uniform spacing of 80 or 200 µm 
(Figure S1 in the supporting information). The membranes were fabricated by the UV-LIGA 
(ultraviolet lithography, electroplating, and molding) process, which involves galvanic 
deposition of nickel onto the template formed by photolithography.24  
The porosity of a membrane with the hexagonal pore array is given by:  
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where dp is the pore diameter and S is the interpore distance. The porosities of the membranes 
calculated from Eq. (1) are given in the supporting information (Table S1).  
Preparation Procedures. PEG-PCL Synthesis. 1 g of PEG and 40% (v/v) ε-CL solution in 
toluene were dissolved in 20 ml of refluxing toluene under nitrogen atmosphere. The mole 
ratio of PEG to ε-CL in the reaction mixture varied from 1:22 to 1:88. The polymerization 
was initiated by the addition of a 20% (v/v) solution of Sn(Oct)2 in toluene (0.75 w/w) and 
carried out at 110 °C under nitrogen atmosphere and constant stirring for 18 h. The PEG-PCL 
copolymer was isolated by precipitation in diethyl ether and dried under vacuum.  
PEG-Hyd-PCL Synthesis. 1 g of PEG-CHO was dissolved in 12 ml of ethanol at 35 oC under 
nitrogen atmosphere and 2-HEH 10% (v/v) solution in ethanol was added in excess 
(CHO/NHNH2 = 1:5). After 48 h, PEG-Hyd-OH was isolated from diethyl ether, washed with 
cold (-18 oC) ethanol and dried under vacuum at 40 oC for 24 h. Polymerization of  ε-CL from 
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PEG-Hyd-OH was carried out under the same conditions used in synthesis of PEG-PCL 
copolymers. 
Micellization and Drug Loading. A schematic diagram of the experimental set-up is shown in 
Figure 1 (b). The cell was filled with 15-35 ml of ultrapure water and the stirring speed was 
adjusted between 400 and 1000 rpm. A 1 mg ml-1 of the copolymer (PEG-PCL-3 or PEG-
PCL-4) was prepared by dissolving the copolymer in THF or acetone. The organic phase was 
injected through the membrane using a peristaltic pump (Watson Marlow 101U, Cornwall, 
UK) at a constant flow rate of 2-8 ml min-1 corresponding to the dispersed phase flux of 142-
568 l m-2 h-1. The experiment was run until a predetermined organic to aqueous phase ratio 
was achieved. Spontaneous formation of micelles started as soon as the organic phase was 
brought in contact with the aqueous phase, but the micelle suspension was kept under stirring 
for 15 min. The suspension was then collected and the organic solvent was removed by 
stirring under vacuum for 24 h. After each experiment, the membrane was sonicated in THF 
for 1 h, followed by soaking in a siloxane-based wetting agent for 30 min. Drug-loaded 
micelles were prepared as described above with the only difference being that 2.5 mg ml-1 
vitamin E was dissolved in the organic phase containing the polymer. 
Polymers Characterization. Gel Permeation Chromatography (GPC). GPC analysis was 
performed on an Agilent 1100 HPLC System equipped with a refractive index detector 
(G1362A) and an Agilent PLgel MIXED-C column, 5 μm, 300 × 7.5 mm, in series with an 
Agilent PLgel guard column, 5 μm, 50 × 7.5 mm. The flow rate of the mobile phase (THF) 
was 1 ml min-1 and the column temperature was 30 °C. The calibration was performed using 
polystyrene standards with a narrow molecular weight distribution (EasiVials PS-M). 
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Fourier Transformed-Infrared Spectroscopy (FTIR). FTIR spectra were obtained using a 
Shimadzu FTIR-8400S spectrometer. A small amount of each material was mixed with KBr 
and compressed to tablets. The IR spectra of these tablets were obtained in absorbance mode 
and in the spectral region of 600 to 4000 cm-1 using a resolution of 4 cm-1 and 64 co-added 
scans. 
Nuclear Magnetic Resonance Spectroscopy (NMR). Polymers were solubilised in deuterated 
chloroform (CDCl3) and 1H-NMR spectra were obtained on a Bruker Ultrashield Av-400 
spectrometer, operating at 400.13 MHz, employing a 5 mm high-resolution broad-band 
ATMA gradients probe. Spectra were recorded using the zg30 pulse program with P90 = 14.5 
μs covering a sweep width of 20.7 ppm (8278 Hz) with 64 k time domain data points giving 
an acquisition time of 3.95 s, Fourier transformed using 128 k data points and referenced to 
an internal TMS standard at 0.0 ppm. 
Micelles Characterization. Particle Size Analysis. Particle size distribution was determined 
by dynamic light scattering (DLS), otherwise known as photon correlation spectroscopy 
(PCS),25-26 using a Malvern Zetasizer Nano-series (Malvern Instruments Zen 3600, Malvern, 
UK). Each sample was diluted 10-fold with ultra-pure water before measurement and 
analyzed in triplicate at 25 °C. The particle size distribution data were generated using the 
DTS nano software (version 5.2). The micelle size polydispersity was expressed by the 
polydispersity index, PDI. 
Zeta Potential. The zeta potential was determined using a Malvern Zetasizer Nano-series 
(Malvern Instruments Zen 3,600, Malvern UK) and measurements were performed at least 
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three times after dilution in water. The zeta potential was calculated from the electrophoretic 
mobility applying the Helmholtz-Smoluchowski equation.27  
Encapsulation Efficiency. The encapsulation efficiency of vitamin E in micelles was 
determined using the ultracentrifugation technique. The total amount of vitamin E (TA) was 
determined after disrupting drug-loaded micelles in ethanol using an ultrasound bath for 10 
min. The amount of vitamin E encapsulated in micelles (EA) was determined by centrifuging 
solutions of vitamin E-loaded micelles using an OptimaTM Ultracentrifuge (Beckman 
Coulter, USA) at 50,000 rpm for 50 min at +4 °C to separate micelles from non-encapsulated 
drug. The resulting micelle sediment was dissolved in ethanol and assayed for encapsulated 
vitamin E content (EA). The vitamin E encapsulation efficiency (E.E.) was calculated as 
follows: 
100/.. ×= TAEAEE              (2) 
E.E. was determined in triplicate. The concentration of vitamin E was measured using an 
HPLC system (Agilent System series 1100, Agilent Technologies, California, USA) consisted 
of a pump, an auto-sampler and a UV/VIS detector. The column used was a LiChrospher RP 
C18 column (5 µm, 15 cm × 0.46 cm) (Supelco, Bellefonte, USA). The separation was 
carried out using a mixture of methanol and water (96:4 v/v) as the mobile phase at a flow 
rate of 1.6 ml min-1. The eluent was monitored at 292 nm and peaks were recorded using the 
chromatography data system software provided by Agilent. The column was equilibrated for 
30 min with a minimum of 30 column volumes. The column was washed after use using 
water - acetonitrile mixture (50:50 v/v) for 60 min. This HPLC analytical method was 
validated (data not shown). 
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Transmission Electrom Microscopy (TEM). TEM observation was carried out according to a 
previously reported protocol.28 Briefly, an aliquot of the micelle solution was diluted 10-fold 
using ultrapure water and a drop of the diluted sample was placed onto a carbon-coated 
copper grid. The sample was allowed to stand for 3 min, after which the excess fluid was 
absorbed by a filter paper leaving a thin liquid film over the holes. One drop of a 1% (w/w) 
sodium silicotungstate solution was then applied and allowed to dry for 2 min. Finally, the 
stained samples were observed and images were taken using a CM 120 microscope (Philips, 
Eindhoven, Netherlands) operating at an accelerating voltage of 80 kV. 
Process Reproducibility. The experiments conducted under the optimum conditions were 
repeated three times in order to estimate reproducibility of the fabrication process. 
pH-Responsive Drug Release. A drug-loaded micelle solution was divided into 4 aliquots 
and the pH of each aliquot was adjusted to 1.9, 4.5, 6.3 and 9.8. pH 1.9 was adjusted by 
potassium phosphate buffer consisting of potassium dihydrogen phosphate and phosphoric 
acid solution. pH 4.5 or 6.3 was adjusted by a buffer solution of potassium dihydrogen 
phosphate and sodium hydrogen phosphate. At pH 9.8, the drug release medium was a buffer 
solution of boric acid and potassium borate. At chosen time intervals, samples were taken and 
encapsulation efficiency was determined using the method previously described. 
RESULTS AND DISCUSSION 
Polymer Characterization. Gel Permeation Chromatography (GPC). The molecular weight 
of the synthesized polymers, as calculated by GPC, is shown in Table 1. The hydrophilic 
fraction, f, is the mass fraction of the hydrophilic block to the total polymer mass and it 
dictates the structure of the micelles. For diblock amphiphilic copolymers, Discher and 
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Eisenberg29 suggest that micelles are formed if f > 0.5; a condition that is satisfied for all four 
synthesized polymers.  
Table 1. Number average molecular weight, Mn, polydispersity index, Mw/Mn, and 
hydrophilic fraction, f, of the synthesized copolymers, as determined by GPC.   
Polymer  PEG/ε-CL mole ratio  in the feed mixture Mn (Da) Mw/Mn f 
PEG-PCL-1 1:22 7400 1.10 0.82 
PEG-PCL-2 1:44 8200 1.14 0.74 
PEG-PCL-3 1:66 9200 1.17 0.67 
PEG-PCL-4 1:88 10400 1.25 0.59 
 
Fourier Transformed-Infrared Spectroscopy (FTIR). FT-IR spectra are presented in Figure 2. 
All materials show characteristic absorbancies for PEG, the C-O-C etheric bond bending 
vibration at 1109 cm-1 and the absorbancies at 842 and 1333 cm-1, attributed to PEG 
crystalline regions. On the PEG-PCL spectra, new absorbances emerge; one at 1724 cm-1 is 
attributed to stretching of the esteric carbonyl, while the two at 2935 and 729 cm-1 are due to 
C-H bond stretching in the PCL block. All absorbancies attributed to the PCL block increase 
in intensity from PEG-PCL-1 to PEG-PCL-4, as the molecular weight of the hydrophobic 
block increases respectively.  
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Figure 2. FT-IR spectra for PEG and the synthesized copolymers. 
 
Nuclear magnetic resonance spectroscopy (NMR). Chemical structure, proton numbering and 
1H-NMR spectra for polymers is shown in Figure 3.  
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Figure 3. Proton numbering and 1H-NMR spectra for PEG and synthesized di-block PEG-
PCL copolymers. 
 
The degree of polymerization, DP, of PCL was calculated using the equation:  
DPPCL = (A4.0/2 )/(A3.3/3) = (A2.3/2)/(A3.3/3)                                                                (3) 
Absorbancies at 4.0 and 2.3 δ are due to protons in the PCL block, while the absorbance at 
3.3 δ is due to the three protons in the methoxy terminal-group of PEG. This allowed the 
calculation of the molecular weight for each polymer using NMR spectroscopy. The Mn 
results presented in Table 2 are in relatively good agreement with those obtained using GPC. 
Table 2. Degree of polymerization, DP, and number average molecular weight, Mn, of the 
synthesized copolymers, as determined by 1H-NMR. 
 
Polymer DP Mn (Da) 
PEG-PCL-1 10 7300 
PEG-PCL-2 13 7600 
PEG-PCL-3 31 9600 
PEG-PCL-4 54 12300 
 
 
Parameters Affecting the Micellization Process. Membrane Used. In order to investigate 
the role of membrane during micellization process, two micelle suspensions were prepared 
under the same operating conditions (agitation speed = 700 rpm and organic phase flow rate = 
4 ml min-1) and using the same formulation (polymer PEG-PCL-4 concentration = 1 mg ml-1, 
organic solvent = THF, and aqueous to organic phase volume ratio = 5). In one experiment, 
the organic phase was injected directly in the aqueous phase, whereas in another experiment 
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the organic phase was passed through the membrane with a pore size of 20 µm and pore 
spacing 80 µm. As shown in Figure 4, the mean particle size of micelle suspension was 552 
nm for direct injection and 132 nm for injection through the membrane. In direct injection 
micromixing occurs after macromixing (breaking macrovolumes of the organic phase into 
microvolumes by agitation), whereas in membrane injection micromixing is a sole means of 
mixing. Therefore, membrane injection is associated with better uniformity of polymer and 
organic solvent distribution through the aqueous phase resulting in a more uniform 
distribution of micelle sizes and significantly smaller particle size.  
 
Figure 4. Size distribution of micelles prepared by direct or membrane injection of the 
organic phase. Experimental conditions: organic phase flow rate = 4 ml min-1, membrane pore 
size = 20 µm, pore spacing = 80 µm, polymer PEG-PCL-4 concentration = 1 mg ml-1, organic 
solvent = THF, agitation speed = 700 rpm, aqueous to organic phase volume ratio = 5. 
 
Aqueous to Organic Phase Volume Ratio, AOR. The particle size distribution of micelles was 
compared by injecting 5 ml of the organic phase through the membrane into respectively 15, 
25 and 35 ml of water (corresponding to an AOR of 3, 5 and 7). As shown in Table 3 and 
Figure 5(a), when the AOR increased from 3 to 7, the mean micelle size decreased from 127 
to 90 nm and the PDI increased from 0.24 to 0.29. A similar behavior was observed during 
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fabrication of liposomes in a hollow fiber module, with the particle size reduction from 189 to 
114 nm as a result of increase in AOR from 0.4 to 2.30 By increasing AOR, the polymer is 
more rapidly dispersed in the aqueous phase due to a higher concentration gradient during 
mixing and the critical micellar concentration (CMC) is reached faster, which means that less 
time is allowed for the polymer molecules to redistribute into larger micelles. In addition, at 
the higher AOR value, micelles are more diluted after mixing with the aqueous phase, which 
may reduce their tendency to aggregation. Based on the obtained results and taking into 
consideration the final micelle concentration and their size and uniformity, the AOR was 
fixed at 5 in the following experiments. 
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Figure 5. The effect of different process parameters on the micelle size distribution: (a) 
Aqueous to organic phase volume ratio, AOR, (b) Agitation speed, (c) Transmembrane flux, 
(d) Polymer molecular weight, and (e) Type of the organic solvent. Other conditions are 
specified in Table 3.  
 
Table 3. Influence of formulation factors and process parameters on micelle size 
characteristics. The membrane pore size was 20 µm and the interpore distance was 200 µm. 
 
 18 
AOR 
Agitation 
speed 
(rpm) 
Flux  
(l m-2 h-1) Polymer used 
Organic 
solvent 
Mean 
size 
(nm) 
PDI 
Zeta 
potential 
(mV) 
3 700 568 PEG-PCL-4 THF 127 0.24 -20.1 
5 700 568 PEG-PCL-4 THF 117 0.28 -27.6 
7 700 568 PEG-PCL-4 THF 90 0.29 -24.2 
5 400 568 PEG-PCL-4 THF 131 0.24 -24.8 
5 1000 568 PEG-PCL-4 THF 82 0.41 -24.0 
5 700 142 PEG-PCL-4 THF 54 0.23 -26.1 
5 700 355 PEG-PCL-4 THF 62 0.26 -24.2 
5 700 568 PEG-PCL-3 THF 49 0.36 -26.8 
5 700 568 PEG-PCL-3 Acetone 41 0.47 -25.0 
 
Agitation Speed. The influence of agitation speed over a range of 400-1000 rpm on the 
micelle size is shown in Table 3 and Figure 5(b). The micelle size decreased from 131 to 82 
nm when the agitation speed increased from 400 to 1000 rpm and the most uniform micelles 
(PDI = 0.24) were obtained at the stirring rate of 400 rpm. The shear stress at the 
membrane/continuous phase interface increases with increasing the stirring rate. It was 
previously found that the particle size in membrane-based particle fabrication processes was 
smaller at the higher wall shear stress,24,31 which was associated with higher mixing 
efficiency.32,33 Thus, high homogenous supersaturation may occur in a short time, leading to 
rapid self-arrangement of polymers and formation of small micelles. Our results suggest that 
for a given set of conditions, an agitator speed of 700 rpm was the optimal speed, since the 
produced micelles were both relatively uniform and of suitable size. 
Transmembrane Flux. As shown in Table 3 and Figure 5(c), by increasing the dispersed 
phase flux from 142 to 568 l m-2 h-1, the mean micelle size increased from 54 to 117 nm and 
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PDI increased from 0.23 to 0.28. The higher dispersed phase flux resulted in the higher 
amount of the polymer injected through the membrane per unit time,34 which has an effect to 
prolong mixing time and reduce the mixing efficiency. The maximum micelle size in Table 3 
corresponds to the maximum polymer concentration at the membrane/continuous phase 
interface. Thus, the largest micelles were formed at the maximum transmembrane flux and 
the minimum agitation speed.  
Copolymer Molecular Weight, MW. The results in Table 3 and Figure 5(d), show that larger 
micelles were prepared using a copolymer with the higher MW. Both polymers are suitable 
for preparation of micelles with a convenient mean size (between 49 and 117 nm) and 
acceptable size distribution (PDI between 0.26 and 0.36) for drug release applications.  
Organic Solvent. Numerous organic solvents have been used for micelle preparation, such as 
methanol,35 THF,36 dimethylsulfoxide,37 N,N-dimethylformamide, and acetone.38 Although 
removed by evaporation, solvents may remain as traces in the final formulation, representing 
a possible risk for human health. In this work, THF and acetone were selected as organic 
solvents due to their low toxicity and good vitamin E and PEG-PCL solubility. Table 3 and 
Figure 5(e) show that the particle size distribution is virtually unaffected by the organic 
solvent used.  
Membrane structure. Micelle suspensions were prepared using 6 different membranes with 
pore diameters of 5, 10, 20 and 40 µm and pore spacing of 80 or 200 µm. At the constant pore 
spacing of 200 µm, a strong linear correlation between the mean micelle size and the 
membrane pore size was found, with a gradient of 2 nm µm-1 and R2 > 0.99, as shown in 
Figure 6. A similar linear relation between the particle size and pore size of microengineered 
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membrane was obtained in fabrication of liposomes39 and membrane emulsification.40-41 The 
results clearly show that the micelle size can be controlled by the membrane pore size. The 
size uniformity increased with decreasing the pore size (Figure 6b). As shown in Table 4, the 
micelle size decreased by 4-10 % as a result of increase in the pore spacing from 80 to 200 
µm. There are two consequences of increasing pore spacing at constant transmembrane flux: 
(i) organic phase stream is fragmented into smaller number of sub-streams, and (ii) the flow 
velocity of each sub-stream is higher. The micromixing is more efficient when at the higher 
velocity of organic phase, probably because the organic phase micro-jets can penetrate deeper 
into the aqueous phase before being disintegrating due to mixing with a surrounding aqueous 
phase.  
Table 4. Influence of membrane on the micelle size characteristics. The experimental 
conditions: aqueous to organic phase volume ratio AOR = 5, organic solvent = THF, polymer 
PEG-PCL-4 concentration: 1 mg ml-1, agitation speed = 700 rpm, transmembrane flux = 568 l 
m-2 h-1. 
Membrane characteristics Micelles size characteristics 
Spacing (µm) Pore size (µm) Mean size (nm) PDI 
200 
5 92 0.17 
10 101 0.19 
20 117 0.28 
40 165 0.38 
80 10 105 0.21 20 130 0.23 
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Figure 6. Effect of the membrane pore size on the micelle size characteristics: (a) mean 
micelle size, and (b) PDI of the micelles. The membrane pore spacing is 200 µm and other 
conditions are specified in Table 4. 
 
Vitamin E Loading. Vitamin E was chosen as a hydrophobic drug for the preparation of 
drug-loaded micelles. This active agent was widely used as an antioxidant in many medical 
and cosmetic preparations and was encapsulated in the micelles by hydrophobic forces, due to 
its affinity to the hydrophobic block of the copolymers, without chemical conjugation. The 
effect of drug entrapment on the vesicle size and zeta potential is presented in Table 5 and 
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Figure 7. The mean micelle size increased from d0 = 92 to d1 = 154 nm when vitamin E was 
encapsulated under otherwise constant experimental conditions. Thermodynamically stable 
drug-loaded micelles can be referred to as “microemulsion droplets” or “swollen micelles” 
and these two terms can be used interchangeably.42 Although there is no single particle size 
that can be used as a definitive cut-off point to distinguish a swollen micelle from a 
conventional emulsion, most authors assume that the mean particle diameter in a stable O/W 
microemulsion should be less than 200 nm.43 Assuming that the micelles are spherical and 
volumes of vitamin E and copolymer are additive, the drug loading percentage is as follows:  
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where ρE = 0.95 g ml-1 is the density of vitamin E and ρPEG-PCL = 1.135 g ml-1 is the density of 
PEG-PCL diblock copolymer, based on melt densities of PEG and PCL homopolymers of 
1.13 and 1.4 g ml-1, respectively. The drug loading calculated using Eq. (3) is 75%, which 
means that vitamin E constitutes 75% of the total mass of a drug-loaded micelle and the 
copolymer 25%. The drug loading can be also estimated from the mass balance of vitamin E. 
It is reasonable to suggest that neither vitamin E nor copolymer was adsorbed onto the 
membrane surface due to low internal pore volume of the membrane. The volume of organic 
phase injected through the membrane was 5 ml, the concentration of vitamin E in the organic 
phase was 2.5 mg ml-1 and the efficiency of vitamin E encapsulation was 87.4 % (Table 5), 
which means that the total amount of vitamin E entrapped within the micelles was 10.9 mg. 
The critical micelle concentration (CMC) of PEG-PCL diblock copolymer with a molecular 
weight of 12600 Da, as determined by GPC, was found to be 0.018 mg ml-1.44 The total 
amount of non-aggregated PEG-PCL-4 molecules in the final preparation was 0.45 mg, based 
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on the volume of aqueous phase in the final preparation of 25 ml and the above value of 
CMC. The concentration of PEG-PCL-4 in the organic phase was 1.0 mg ml-1 and thus, the 
total amount of PEG-PCL-4 incorporated in the micelles was 4.55 mg. The drug loading 
estimated from the process mass balance is now: 10.9/(4.55+10.9)×100=71%, which is close 
to 75%, calculated from Eq. 3. A small difference can be attributed to the fact that Eq. (3) 
does not take into account the effect of molecular interactions on the volumes of vitamin E 
and copolymers in the micelles.  
The zeta-potential of vitamin E-loaded micelles and drug-free micelles was -19.3 and -27.0 
mV, respectively (Table 5), which can be attributed to the presence of terminal carboxyl 
groups on PCL chains. Zeta potential measurements can give information about the type of 
association between the active substance and the carrier,45 for example whether the drug is 
encapsulated in the core material or adsorbed onto the shell.46 Here, the negative surface 
charge was partially shielded in the presence of the drug suggesting that at a small part of the 
drug might have been adsorbed onto the surface, while the rest was incorporated within the 
micelle cores. The zeta potential data suggest that the micelles should exhibit a good colloidal 
stability, since a negative zeta potential near or lower than -20 mV was found to prevent 
vesicle coalescence.47 A high encapsulation efficiency of 87.4% was probably due to the high 
hydrophobicity of the vitamin E as many studies reported that the encapsulation efficiency 
was proportional to the drug solubility in the organic phase.48 Drug-loaded micelles were 
more uniform in size than unloaded micelles as evidenced by the lower PDI value in Table 5. 
It was found that core-entrapping drug, in this case α-tocopherol, may act as a filler molecule 
and enhance the stability of the micelle.49 
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Table 5. The effect of vitamin E loading on the micellization process. Organic solvent: THF, 
polymer PEG-PCL-4 concentration = 1 mg ml-1, vitamin E concentration in the organic phase 
= 2.5 mg ml-1, agitation speed = 700 rpm, AOR = 5, transmembrane flux = 568 l m-2 h-1. 
 
 Size (nm) PDI Zeta potential (mV) Encapsulation efficiency (%) 
Drug-free micelles 92 0.17 -27.0  
Drug-loaded micelles 154 0.09 -19.3 87.4 
 
 
Figure 7. The effect of loading vitamin E into micelles on their size distribution. The 
experimental conditions are specified in Table 5. 
 
Process Reproducibility. The reproducibility of the preparation technique was investigated 
by repeating 3 times a typical micellization experiment with and without drug loading. The 
results in Figure 8 and Table S2 suggest a very good reproducibility in terms of size 
characteristics, zeta potential and encapsulation efficiency between the samples produced 
under the same conditions. 
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Figure 8. Reproducibility of the micelle preparations: (a) Drug-free micelles and (b) Drug-
loaded micelles. Experimental conditions are specified in Table 5. 
 
TEM Observation. Figure 9 revealed nanometric, quasi-spherical shape of vitamin E-loaded 
micelles. According to this morphological investigation, micelles ranged in size from 100 to 
200 nm, which is in good correlation with the dynamic light scattering measurements.  
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Figure 9. TEM micrograph of vitamin E-loaded micelles. 
 
pH-Responsive Drug Release. The release of vitamin E from micelle preparations stored 
under different pH conditions was monitored as a function of time. The results in Figure 10 
show that the micelles kept under acidic pH were unstable due to hydrolysis of the ester 
bonds in the PCL block and formation of 6-hydroxycaproic acid. Since vitamin E is 
predominantly encapsulated within a hydrophobic core, hydrolytic degradation of 
hydrophobic PCL segments led to the release of vitamin E. A decrease in the drug 
encapsulation efficiency was proportional to the medium acidity, because PCL hydrolysis 
was catalyzed by hydrogen ions. Indeed, within 50 hours, the encapsulation efficiency 
decreased from an initial value of 89.2% to 83.2, 79.5 and 68.3% at the pH of 6.3, 4.5 and 
1.9, respectively. When the micelles were stored at the pH of 9.8, no release of vitamin E 
occurred and the encapsulation efficiency remained nearly unchanged.  
200 nm
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Figure 10. Time evolution of the encapsulation efficiency of vitamin E-loaded micelles 
stored under different pH conditions. 
 
Preparation of PEG-Hyd-PCL Micelles. The maximum percent of vitamin E released from 
PEG-PCL micelles after 50 h was 23 % at pH = 1.9. In order to increase the release rate and 
pH sensitivity at mildly acidic pH, we have synthesized highly pH sensitive PEG-Hyd-PCL 
micelles by incorporating a pH-sensitive hydrazone bond between the PEG and PCL blocks. 
When the micelles are exposed to mildly acidic pH, the bond hydrolyzes and the micelle 
collapses releasing the drug. We have prepared PEG-PCL and PEG-Hyd-PCL micelles under 
the same conditions by transferring 5 ml of the organic phase containing 5 mg ml-1 of each 
polymer dissolved in THF to 25 ml of deionized water at the flow rate of 0.5 ml min-1 and pH 
= 7.4 to obtain the final micelle concentration of 1 mg ml-1 and AOR = 5. The micelle 
suspension was gently stirred for 6 hours and any residual THF was removed with vacuum 
distillation. As can be seen in Figure 11, both micelle types were found to show identical 
micellization behaviour forming micelles of identical particle size distribution. It shows that 
the micellization behavior is determined only by the type of the hydrophobic and hydrophilic 
block and molecular weight of the polymer and not by the presence of hydrazone bond. The 
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main difference between the two micelle types was in a higher pH sensitivity of PEG-Hyd-
PCL micelles. We have confirmed the hydrolysis of hydrazone bond by GPC, showing 
bimodal MW distributions in PEG-Hyd-PCL dispersions exposed to pH< 6, whereas the MW 
distribution was monomodal at neutral pH. The hydrolysis leads to the dissolution of the PEG 
blocks and the release of the PCL blocks and the entrapped drug. This was confirmed by 
optical transmittance and DLS measurements in PEG-Hyd-PCL dispersions at pH<6. By 
decreasing pH, the transmittance of PEG-Hyd-PCL dispersions at 500 nm decreased 
significantly, while the average particle size increased, which can be both explained by the 
agglomeration of released PCL blocks. 
 
Figure 11. Particle size distributions of micelles composed of PEG-PCL and PEG-Hyd-PCL 
copolymers. The molecular weight of PEG and PCL block was the same in both copolymers.  
 
CONCLUSIONS 
Di-block copolymers composed of hydrophilic poly(ethylene) glycol (PEG) and hydrophobic 
polycaprolactone (PCL) segments were successfully synthesized, characterized, and used for 
the preparation of pH sensitive PEG-PCL micelles using a new membrane dispersion method. 
The organic phase composed of a mixture of the copolymer and a volatile organic solvent was 
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split into numerous microscopic sub-streams by injection through a microsieve membrane 
and mixed with an agitated aqueous phase. A precise control over the micelle size and size 
distribution was achieved by controlling the pore size and interpore distance of the 
membrane, molecular weight of the copolymer, solvent type, and micromixing conditions in 
the stirred cell device, such as transmembrane flux, aqueous to organic phase ratio, and 
agitation speed. The micelles were obtained with a sufficiently small mean size, satisfying 
zeta potential, and high encapsulation efficiency of a hydrophobic drug (vitamin E), and can 
be used as a pH-sensitive delivery system. The preparation technique is simple, fast, 
reproducible, and has a potential for an industrial scale-up. 
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